Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iasis Pharmaceuticals is a prominent Greek pharmaceutical company focused on the development, manufacturing, and marketing of high-quality generic and branded generic pharmaceutical products. The company operates state-of-the-art manufacturing facilities and a dedicated research and development center, specializing in a wide range of therapeutic areas including endocrinology, cardiology, and respiratory medicine. Iasis is well-known for its significant market share in the Greek diabetes market with its metformin-based products and maintains a strong export presence in international markets. The company also provides contract manufacturing services (CMO) to other pharmaceutical entities, leveraging its EU-GMP certified production lines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iasis Pharmaceuticals Hellas.